Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule
Open Access
- 1 April 2015
- journal article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. ume 10, 2951-2969
- https://doi.org/10.2147/ijn.s79879
Abstract
Objective: Graphene represents a monolayer or a few layers of sp2-bonded carbon atoms with a honeycomb lattice structure. Unique physical, chemical, and biological properties of graphene have attracted great interest in various fields including electronics, energy, material industry, and medicine, where it is used for tissue engineering and scaffolding, drug delivery, and as an antibacterial and anticancer agent. However, graphene cytotoxicity for ovarian cancer cells is still not fully investigated. The objective of this study was to synthesize graphene using a natural polyphenol compound resveratrol and to investigate its toxicity for ovarian cancer cells. Methods: The successful reduction of graphene oxide (GO) to graphene was confirmed by UV-vis and Fourier transform infrared spectroscopy. Dynamic light scattering and scanning electron microscopy were employed to evaluate particle size and surface morphology of GO and resveratrol-reduced GO (RES-rGO). Raman spectroscopy was used to determine the removal of oxygen-containing functional groups from GO surface and to ensure the formation of graphene. We also performed a comprehensive analysis of GO and RES-rGO cytotoxicity by examining the morphology, viability, membrane integrity, activation of caspase-3, apoptosis, and alkaline phosphatase activity of ovarian cancer cells. Results: The results also show that resveratrol effectively reduced GO to graphene and the properties of RES-rGO nanosheets were comparable to those of chemically reduced graphene. Biological experiments showed that GO and RES-rGO caused a dose-dependent membrane leakage and oxidative stress in cancer cells, and reduced their viability via apoptosis confirmed by the upregulation of apoptosis executioner caspase-3. Conclusion: Our data demonstrate a single, simple green approach for the synthesis of highly water-dispersible functionalized graphene nanosheets, suggesting a possibility of replacing toxic hydrazine by a natural and safe phenolic compound resveratrol, which has similar efficacy in the reduction of GO to rGO. Resveratrol-based GO reduction would facilitate large-scale production of graphene-based materials for the emerging graphene-based technologies and biomedical applications.Keywords
This publication has 79 references indexed in Scilit:
- Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cellsColloids and Surfaces B: Biointerfaces, 2013
- In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cellsInternational Journal of Nanomedicine, 2013
- Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer CellsBioMed Research International, 2013
- Synthesis of gold and silver nanoparticles using purified URAKColloids and Surfaces B: Biointerfaces, 2011
- High-Quality Thin Graphene Films from Fast Electrochemical ExfoliationACS Nano, 2011
- Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal TherapyNano Letters, 2010
- Reduction of graphene oxide vial-ascorbic acidChemical Communications, 2009
- Evidence of Graphitic AB Stacking Order of Graphite OxidesJournal of the American Chemical Society, 2008
- Caspases and apoptosisEssays in Biochemistry, 2002
- Chemotherapy for advanced epithelial ovarian carcinomaBest Practice & Research Clinical Obstetrics & Gynaecology, 2002